ijms-logo

Journal Browser

Journal Browser

Molecular Determinants Involved in the Docking and Uptake of Extracelullar Vesicles in Cancer and Immune System

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: closed (28 February 2023) | Viewed by 6072

Special Issue Editors


E-Mail Website1 Website2
Guest Editor
Department of Molecular Biology, Universidad Autónoma de Madrid (UAM), 28049 Madrid, Spain
Interests: extracellular vesicles; exosomes; tetraspanins; adhesion molecules

E-Mail Website
Guest Editor
Vascular Biology and Inflammation Department, Centro Nacional Investigaciones Cardiovasculares (CNIC), 28029 Madrid, Spain
Interests: intercellular communication; immune cells; exosomes; extracellular vesicles; microRNAs; adhesion molecules

E-Mail Website
Guest Editor
Cell-Cell Communication & Inflammation Unit, Centre for Molecular Biology “Severo Ochoa” (CSIC-UAM), 28049 Madrid, Spain
Interests: cell-cell communication; adhesion molecules; integrins; extracellular vesicles; tumor development and progression
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues, 

We are delighted to announce a call for submissions to a Special Issue of the International Journal of Molecular Sciences on the topic: “Molecular Determinants and Mechanisms Involved in Docking and Uptake of Extracellular Vesicles: Implications in Cancer and the Immune System”.

Extracellular vesicles (EVs) comprise a heterogeneous group of vesicular structures that are released by almost all cell types under both normal and pathological conditions and play crucial roles in intercellular communication in metazoan organisms.

In the immune system, EVs are involved in cell-to-cell communication amongst immune cells, regulating the initiation, activation and modulation of immune responses, through their roles in innate cell differentiation, antigen presentation, activation and polarization of NK, B and T lymphocytes and immune suppression and inflammation.

In cancer, EVs released by malignant cells promote tumour development, progression, chemoresistance and metastasis through a variety of mechanisms, including immune suppression.

In order to exert their functional roles in intercellular communication, EVs released by donor/producing cells must interact (“EV docking”) with target/acceptor cells, a process that is normally followed by their uptake by these recipient cells, resulting in the delivery of their biomolecular cargo that is responsible for induction of phenotypical and functional changes in these cells. Importantly, although the involvement of EVs in immune response regulation and in cancer-related processes is well established, knowledge on the specific molecules and mechanisms involved in the docking and uptake of EVs by the plethora of recipient target cells in cancer and immune system is still rather scarce. The focus in this Special Issue is to improve the understanding of the molecular determinants (adhesion molecules and their ligands, immune checkpoints, apoptosis inducers, co-stimulatory molecules, regulatory tetraspanins, etc.) and of the mechanisms (endocytosis, phagocytosis, micropinocytosis, membrane fusion, etc.) that are involved in the docking and uptake of extracellular vesicles by recipient cells and their implications in cancer and the immune response.

This Special Issue of IJMS welcomes both original research and review articles. All submitted articles will undergo a rigorous peer-review process.

Dr. María Yáñez-Mó
Dr. Francisco Sánchez-Madrid
Dr. Carlos Cabañas
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

20 pages, 3740 KiB  
Article
ALCAM/CD166 Is Involved in the Binding and Uptake of Cancer-Derived Extracellular Vesicles
by Beatriz Cardeñes, Irene Clares, Tamara Bezos, Víctor Toribio, Soraya López-Martín, Almudena Rocha, Héctor Peinado, María Yáñez-Mó and Carlos Cabañas
Int. J. Mol. Sci. 2022, 23(10), 5753; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms23105753 - 20 May 2022
Cited by 9 | Viewed by 3054
Abstract
Colorectal cancer (CRC) and ovarian cancer (OvC) patients frequently develop peritoneal metastasis, a condition associated with a very poor prognosis. In these cancers, tumor-derived extracellular vesicles (EVs) cause immunosuppression, facilitate the direct attachment and invasion of cancer cells through the mesothelium, induce the [...] Read more.
Colorectal cancer (CRC) and ovarian cancer (OvC) patients frequently develop peritoneal metastasis, a condition associated with a very poor prognosis. In these cancers, tumor-derived extracellular vesicles (EVs) cause immunosuppression, facilitate the direct attachment and invasion of cancer cells through the mesothelium, induce the conversion of peritoneal mesothelial cells (PMCs) into cancer-associated fibroblasts (CAFs) and transfer a more aggressive phenotype amongst cancer cells. Although the promoting role of EVs in CRC and OvC peritoneal metastasis is well established, the specific molecules that mediate the interactions between tumor-derived EVs and immune and non-immune target cells remain elusive. Here, we employed the SKOV-3 (ovarian adenocarcinoma) and Colo-320 (colorectal adenocarcinoma) human cell lines as model systems to study the interactions and uptake of EVs produced by ovarian carcinoma and colorectal carcinoma cells, respectively. We established that the adhesion molecule ALCAM/CD166 is involved in the interaction of cancer-derived EVs with recipient cancer cells (a process termed “EV binding” or “EV docking”) and in their subsequent uptake by these cells. The identification of ALCAM/CD166 as a molecule mediating the docking and uptake of CRC and OvC-derived EVs may be potentially exploited to block the peritoneal metastasis cascade promoted by EVs in CRC and OvC patients. Full article
Show Figures

Figure 1

Review

Jump to: Research

22 pages, 1329 KiB  
Review
Molecular Docking and Intracellular Translocation of Extracellular Vesicles for Efficient Drug Delivery
by Yasunari Matsuzaka and Ryu Yashiro
Int. J. Mol. Sci. 2022, 23(21), 12971; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms232112971 - 26 Oct 2022
Cited by 2 | Viewed by 2460
Abstract
Extracellular vesicles (EVs), including exosomes, mediate intercellular communication by delivering their contents, such as nucleic acids, proteins, and lipids, to distant target cells. EVs play a role in the progression of several diseases. In particular, programmed death-ligand 1 (PD-L1) levels in exosomes are [...] Read more.
Extracellular vesicles (EVs), including exosomes, mediate intercellular communication by delivering their contents, such as nucleic acids, proteins, and lipids, to distant target cells. EVs play a role in the progression of several diseases. In particular, programmed death-ligand 1 (PD-L1) levels in exosomes are associated with cancer progression. Furthermore, exosomes are being used for new drug-delivery systems by modifying their membrane peptides to promote their intracellular transduction via micropinocytosis. In this review, we aim to show that an efficient drug-delivery system and a useful therapeutic strategy can be established by controlling the molecular docking and intracellular translocation of exosomes. We summarise the mechanisms of molecular docking of exosomes, the biological effects of exosomes transmitted into target cells, and the current state of exosomes as drug delivery systems. Full article
Show Figures

Figure 1

Back to TopTop